Lostam BioPharmaceuticals Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Lostam BioPharmaceuticals General Information


Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Nazareth Industrial Area
  • PO Box 2252
  • Nazareth 16000
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lostam BioPharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Lostam BioPharmaceuticals’s complete valuation and funding history, request access »

Lostam BioPharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Lewis Neville Ph.D Founder, Chief Technology Officer & Chief Executive Officer
To view Lostam BioPharmaceuticals’s complete executive team members history, request access »